Aclaris Therapeutics (0H8T.LSE) Q2 2024 Earnings

May 7Confirmed
Q2 2024
-0.29
-0.27
-0.26
-0.24

Details

Expected EPS
-0.285714
Actual EPS
-0.24
Surprise EPS
0.05
Surprise Percent
+16%

Description

⁨Aclaris Therapeutics⁩ (⁦0H8T.LSE⁩) has reported earnings of ⁦-0.24⁩ per share for ⁦Q2 2024⁩.

0 Comments

Share your thoughts